Anatoly Dritschilo M.D
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anatoly Dritschilo M.D
Anatoly Dritschilo M.D is recorded as CEO at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 15, 2025 that Anatoly Dritschilo M.D resigned as director, effective May 9, 2025. Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 15, 2025 that Anatoly Dritschilo M.D resigned as Chief Scientific Offer, effective May 9, 2025. The proxy statement of Shuttle Pharmaceuticals Holdings, Inc. reports total compensation of $334,166 for Anatoly Dritschilo M.D in fiscal 2025, including a base salary of $109,525. Disclosed compensation is on record for 5 fiscal years.
“On May 9, 2025, Dr. Anatoly Dritschilo, resigned as Chief Scientific Offer and director of Shuttle Pharmaceuticals Holdings, Inc. (the "Company"), effective immediately.”
“On May 9, 2025, Dr. Anatoly Dritschilo, resigned as Chief Scientific Offer and director of Shuttle Pharmaceuticals Holdings, Inc. (the "Company"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Shuttle Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Cooper CEO, CFO
- Ryan Trasolini CEO
- George Scorsis Chairman, Board Member
- Michael Vander Hoek CFO
- Timothy J. Lorber CFO
- Timothy Lorber CFO
- Anatoly Dritschilo CTO
- Adam Chambers Board Member
- Angel Liriano Board Member
- Bette Jacobs Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | former CEO | $109,525 | $334,166 |
| 2024 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | CEO\ | $274,000 | $274,000 |
| 2023 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | CEO\ | $287,175 | $399,175 |
| 2022 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | CEO | $97,253 | $268,921 |
| 2021 | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | CEO | $18,829 | $190,497 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.